Cargando…
Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions
BACKGROUND: The current paradigm for cord blood transplantation is that HLA matching and immune suppression are strictly required to prevent graft versus host disease (GVHD). Immunological arguments and historical examples have been made that the use of cord blood for non-hematopoietic activities su...
Autores principales: | Yang, Wan-Zhang, Zhang, Yun, Wu, Fang, Min, Wei-Ping, Minev, Boris, Zhang, Min, Luo, Xiao-Ling, Ramos, Famela, Ichim, Thomas E, Riordan, Neil H, Hu, Xiang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922090/ https://www.ncbi.nlm.nih.gov/pubmed/20682053 http://dx.doi.org/10.1186/1479-5876-8-75 |
Ejemplares similares
-
Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report
por: Ichim, Thomas E, et al.
Publicado: (2010) -
Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with Hereditary Ataxia
por: Yang, Wan-Zhang, et al.
Publicado: (2011) -
Feasibility investigation of allogeneic endometrial regenerative cells
por: Zhong, Zhaohui, et al.
Publicado: (2009) -
Combination stem cell therapy for heart failure
por: Ichim, Thomas E, et al.
Publicado: (2010) -
Immunity Enhancement in Immunocompromised Gastrointestinal Cancer Patients with Allogeneic Umbilical Cord Blood Mononuclear Cell Transfusion
por: Qiu, Ying, et al.
Publicado: (2017)